May 2019: RIENK was invited to join the Bureau of Foreign Investment of the Netherlands (NFIA) organized seminar on “regulatory and innovative areas of providing new drugs and treatment solutions to the European patient community”.This informative and interesting seminar was hosted by the Embassy of the Netherlands in China and the Consulate General of the Netherlands in Shanghai and brought together experts from the Netherlands and China from regulatory, scientific and industrial sectors. Amongst the speakers were the chairman of the Netherlands Clinical Research Regulatory Agency, the Netherlands Drug Appraisal Regulatory Agency and members of the Sub-Committee on Supervision of the Netherlands Medical Association.
Mar 2019: RIENK is supporting Sysbiotech China, a well established design and manufacturing company offering R&D and GMP processing solutions for biotechnology, biopharma and agriculture markets. The cutting-edge processing solutions portfolio includes a range of automated/controlled processing equipment (mixing, holding and deactivation vessels, fermentation and bioreactor systems, CIP/SIP systems and more), and further includes clean-room engineering, process design/optimization, equipment customization and revitalization services. Sysbiotech China is taking an innovative approach to International collaboration and use of technology to meet the client’s ever-changing needs. Their willingness to change, be flexible and continually challenge quality, safety and efficiencies has resulted in cost savings that they are happy to share.
Dec 2018: RIENK is supporting GZL China, a biotech company offering contract research services and a full suite of custom protein services and reagents for drug discovery and Life Science research. The company’s unique technology offers high throughput, high productivity and fast return of purified target product with fully documented quality test reporting, using cell free protein synthesis and recombinant protein expression services. GZL contract research services include target validation studies, high-throughput assay screening, structural biology research, protein-protein interaction studies, diagnostics and biologics development, in vivo & toxicology studies, novel drug development and industrial production downstream optimization (e.g. protein purification and renaturation).
Mar 2018: RIENK is supporting COPro Biotech Co., Ltd with their International Business development activities. COPro Biotech is a relatively new Biotechnology company located in Beijing China, whose main activities are:
(i) promoting advanced Life Science technologies and products in China,
(ii) supporting Chinese biotechnology customers with technology development and tech-transfer, and
(iii) international commercialization and partnering.
Aug 2018: RIENK is supporting Shanghai Bio-Tech Co., Ltd. with the International expansion of their Biomedical products portfolio, for use with Biotechnology and Biopharmaceutical research and QC applications. Shanghai Bio-Tech is a well established and worldwide known supplier of Gel Imaging and Documentation systems for use with DNA/RNA, protein and enzyme gel analysis. The company offers a broad range of laboratory equipment and consumables for biotechnology research and cell culturing applications.